Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01817894Phase 4Completed
A Phase 4 trial of eflornithine in hirsutism, sponsored by Bispebjerg and Frederiksberg Hospital. Started Jan 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01817894.